Who's Who in Anti-Aging and Regenerative Medicine
Week of July 20, 2009
Eric Braverman, MD
Director of PATH Medical
Dr. Braverman is Director of PATH Medical, a national network of affiliated medical professionals. He received his B.A. Summa Cum Laude from Brandeis University and his M.D. with honors from New York University Medical School, after which he performed postgraduate work in Internal Medicine with a Yale Medical School affiliate.
At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Braverman will present, Detecting Silent Diseases: Failure of Current Medical Standards, on Friday, September 11th. In this Lecture, Dr. Braverman will focus on the silent diseases that are generally ignored by the medical community such as sarcopenia, obesity, osteopenia, early kidney failure, parathyroid disorders, and various forms of early heart disease.
For more information call the A4M today;1-888-997-0112.
Health Headlines MORE »
For every 10 g per day increase in soluble fiber intake, a woman may reduce her risk of breast cancer by up to 26%.
Peptides from soybeans modulate neurotransmitters, thereby helping to boost circulation in the brain.
Capsaicin (found in hot peppers) and capsiates (present in sweet peppers) exert modest weight management benefits.
While over 20% of U.S. adults receive periodic health examinations each year, many do not receive recommended preventive screening tests and counseling services
Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
